Skip to main content

Search results for "surrogate endpoints"

Filters: Consensus Study Reports Consensus Study Reports ×
Viewing 1 - 20 of 61 results by relevance
Consensus Study Report

Evaluation of Biomarkers and Surrogate Endpoints in Chronic Disease  (2010)

Consensus Study Report

Enhancing Food Safety: The Role of the Food and Drug Administration  (2010)

Consensus Study Report

Scientific Standards for Studies on Modified Risk Tobacco Products  (2012)

Forum on Neuroscience and Nervous System Disorders: 2014 Annual Report  (2015)

Consensus Study Report

Ethical and Scientific Issues in Studying the Safety of Approved Drugs  (2012)

Consensus Study Report

Modern Methods of Clinical Investigation  (1990)

Consensus Study Report

Rare Diseases and Orphan Products: Accelerating Research and Development  (2010)

Consensus Study Report

Guiding Principles for Developing Dietary Reference Intakes Based on Chronic Disease  (2017)

Consensus Study Report

Evolution of Translational Omics: Lessons Learned and the Path Forward  (2012)

Consensus Study Report

Sodium Intake in Populations: Assessment of Evidence  (2013)

Consensus Study Report

The Future of Drug Safety: Promoting and Protecting the Health of the Public  (2007)

Consensus Study Report

Methodological Challenges in Biomedical HIV Prevention Trials  (2008)

Consensus Study Report

Federal Agency Roles in Cancer Drug Development from Preclinical Research to New Drug Approval: The National Cancer Institute and the Food and Drug Administration  (2005)

Consensus Study Report

Recognition and Alleviation of Distress in Laboratory Animals  (2008)

Consensus Study Report

Review of NASA's Evidence Reports on Human Health Risks: 2016 Letter Report  (2017)

Consensus Study Report

Initial National Priorities for Comparative Effectiveness Research  (2009)

Consensus Study Report

Biomarker Tests for Molecularly Targeted Therapies: Key to Unlocking Precision Medicine  (2016)

Consensus Study Report

Safe and Effective Medicines for Children: Pediatric Studies Conducted Under the Best Pharmaceuticals for Children Act and the Pediatric Research Equity Act  (2012)